Cannabis &amp; Cancer - Kidney

Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation

2022·Laboratory Study -

Negative

The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling

2022·Review/Other

Negative

Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study

Cannabinoids as anticancer drugs: current status of preclinical research

The perceptions and beliefs of cannabis use among Canadian genitourinary cancer patients

In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center

Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank

Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey

2021·Review/Other

Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management

2021·Review/Other

Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies

2019·Review/Other

Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers

2019·Meta-analysis -

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma.

2018·Review/Other

The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.

2016·Review/Other

Cannabinoid CB1 Receptor Is Downregulated In Clear Cell Renal Cell Carcinoma

2010·Review/Other

Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells.

2008·Review/Other